NovoCure GAAP EPS of -$0.22 beats by $0.19, revenue of $174.35M beats by $0.99M
Source: SeekingAlpha
2026-02-26 07:03:46 ET
Read the full article on Seeking Alpha
For further details see:
NovoCure GAAP EPS of -$0.22 beats by $0.19, revenue of $174.35M beats by $0.99M
NovoCure Limited
NASDAQ: NVCR
NVCR Trading
-4.47% G/L:
$13.15 Last:
488,405 Volume:
$13.64 Open:
NVCR Latest News
March 02, 2026 07:00:00 am
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
February 26, 2026 07:00:00 am
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
NVCR Stock Data
$1,170,211,701
105,800,576
0.07%
77
N/A
Medical Equipment & Supplies
Healthcare
JE
St. Helier
